Cargando…
Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
BACKGROUND: Alopecia areata (AA) is an immune disease characterized by non-scarring hair loss. With the widespread application of JAK inhibitors in immune-related diseases, attention is being given to their role in the treatment of AA. However, it is unclear which JAK inhibitors have a satisfactory...
Autores principales: | Wei, Dongfan, Chen, Yi, Shen, Yuqing, Xie, Bo, Song, Xiuzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150113/ https://www.ncbi.nlm.nih.gov/pubmed/37138884 http://dx.doi.org/10.3389/fimmu.2023.1152513 |
Ejemplares similares
-
Novel potential therapeutic targets of alopecia areata
por: Xu, Wen, et al.
Publicado: (2023) -
The potential of regulatory T cell-based therapies for alopecia areata
por: Wan, Sheng, et al.
Publicado: (2023) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022) -
The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
por: Mao, Mei-qi, et al.
Publicado: (2023) -
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
por: Yan, Diqin, et al.
Publicado: (2022)